NYSE:INSP - New York Stock Exchange, Inc. - US4577301090 - Common Stock - Currency: USD
177.32
-1.07 (-0.6%)
The current stock price of INSP is 177.32 USD. In the past month the price decreased by -5.47%. In the past year, price decreased by -4.12%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Inspire Medical Systems, Inc. engages in the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea. The company is headquartered in Golden Valley, Minnesota and currently employs 1,011 full-time employees. The company went IPO on 2018-05-03. The firm is focused on the development and commercialization of advanced, minimally invasive solutions for patients with obstructive sleep apnea (OSA). Its proprietary Inspire therapy is the FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The firm sells its Inspire system to hospitals and ambulatory surgery centers (ASCs) in the United States (U.S.) and in select countries in Europe and Japan through a direct sales organization and sells its Inspire system in Singapore and Hong Kong through distributors. Its direct sales force engages in sales efforts and promotional activities focused on ear, nose and throat (ENT) physicians and sleep centers.
INSPIRE MEDICAL SYSTEMS INC
5500 Wayzata Blvd Ste 1600
Golden Valley MINNESOTA 55416 US
CEO: TimothyP. Herbert
Employees: 1011
Company Website: https://www.inspiresleep.com/
Investor Relations: https://investors.inspiresleep.com/
Phone: 17639575037
The current stock price of INSP is 177.32 USD. The price decreased by -0.6% in the last trading session.
The exchange symbol of INSPIRE MEDICAL SYSTEMS INC is INSP and it is listed on the New York Stock Exchange, Inc. exchange.
INSP stock is listed on the New York Stock Exchange, Inc. exchange.
25 analysts have analysed INSP and the average price target is 240.65 USD. This implies a price increase of 35.72% is expected in the next year compared to the current price of 177.32. Check the INSPIRE MEDICAL SYSTEMS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
INSPIRE MEDICAL SYSTEMS INC (INSP) has a market capitalization of 5.26B USD. This makes INSP a Mid Cap stock.
INSPIRE MEDICAL SYSTEMS INC (INSP) currently has 1011 employees.
INSPIRE MEDICAL SYSTEMS INC (INSP) has a support level at 172.7 and a resistance level at 179.84. Check the full technical report for a detailed analysis of INSP support and resistance levels.
The Revenue of INSPIRE MEDICAL SYSTEMS INC (INSP) is expected to grow by 18.75% in the next year. Check the estimates tab for more information on the INSP EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
INSP does not pay a dividend.
INSPIRE MEDICAL SYSTEMS INC (INSP) will report earnings on 2025-05-05, after the market close.
The PE ratio for INSPIRE MEDICAL SYSTEMS INC (INSP) is 102.5. This is based on the reported non-GAAP earnings per share of 1.73 and the current share price of 177.32 USD. Check the full fundamental report for a full analysis of the valuation metrics for INSP.
The outstanding short interest for INSPIRE MEDICAL SYSTEMS INC (INSP) is 8.67% of its float. Check the ownership tab for more information on the INSP short interest.
ChartMill assigns a fundamental rating of 6 / 10 to INSP. While INSP has a great health rating, its profitability is only average at the moment.
Over the last trailing twelve months INSP reported a non-GAAP Earnings per Share(EPS) of 1.73. The EPS increased by 333.78% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 6.67% | ||
ROA | 6.62% | ||
ROE | 7.76% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 79% to INSP. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 27.77% and a revenue growth 18.75% for INSP